Dubai PR Network, Online Press Release from Dubai and Middle East
 
Health & Fitness(Healthcare & Medicine)
Filter PR by
  
Cleveland Clinic Research Confirms No Association Between Certain Chronic-Disease Medications and COVID-19
 

New study supports recommendations that patients should continue to take ACE Inhibitors, ARBs commonly prescribed for coronary artery disease, heart failure, diabetes and hypertension


 
Dubai, United Arab Emirates, June 07, 2020:  Despite recent controversy suggesting that popular medications prescribed to lower blood pressure may increase the risk of infection by the novel coronavirus and lead to more severe outcomes in COVID-19, a retrospective study by Cleveland Clinic has supported the view that there is no foundation to these claims, although the researchers called for larger studies as the pandemic develops.


The medications in question are Angiotensin-converting enzyme (ACE) inhibitors and Angiotensin II receptor blockers (ARBs), both of which dilate blood vessels to increase the amount of blood pumped by the heart. The result is lowered blood pressure and increased blood flow, which helps to lower the heart’s workload and reduce the risk of heart failure. The medications are commonly prescribed in cases of coronary artery disease, heart failure, diabetes and hypertension (high blood pressure).


“Our analysis found no association between ACEI or ARB use and COVID-19 test positivity,” says Cleveland Clinic cardiologist Ankur Kalra, MD, the study’s corresponding author. 


He adds: “These medications are important tools in the management of coronary artery disease, heart failure, diabetes and hypertension. As there may be a risk to withdrawing these agents, our findings support current professional society guidelines to not discontinue ACEI or ARB therapy in the context of the COVID-19 pandemic.”


A secondary analysis among COVID-19-positive patients showed no association between use of these medications and risk for mechanical ventilation.
The researchers note, however, that further studies are needed to yield more definitive answers, particularly on the question of whether and how ACEI or ARB therapy may impact COVID-19 severity.


First study author Neil Mehta, MD of the Department of Medicine at the Cleveland Clinic Lerner College of Medicine, says: “Our findings with regard to clinical outcomes and measures of COVID-19 severity while on ACEI or ARB therapy give some reassurance. However, they must be interpreted with caution, due to the small sample size and the limitations of observational studies. They require replication and reanalysis in larger patient samples later in the course of the ongoing COVID-19 pandemic.” 


The Cleveland Clinic study looked at 18,472 individuals tested for COVID-19 at its locations in Florida and Ohio, with a mean age of 49 (± 21 years), and who were predominantly female (60%) and white (69%). Testing for COVID-19 was positive in 1,735 patients, or 9.4% of the total sample.

 


Posted by : Dubai PR Network Editorial Team
Viewed 3910 times
PR Category : Healthcare & Medicine
Posted on : Sunday, June 7, 2020  11:23:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Top 10 Things Patients Consider While Choosing an IVF Facil...
Next Story : UAE Hemophilia Group Supports Arab World Celebrations of Int...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Pandora ME for Every Side of You [5646-Views]
Your Guide to Choosing the Right Face Mask [4211-Views]
10 Million Plastic Packaging Saved: Grohe Launches Initiative to Reduce Plastic [3350-Views]
Meet the #Sephorasquad Middle East Members! [2977-Views]
Karl Lagerfeld Announces Collaboration With Designer Kenneth Ize [2657-Views]
Taste the Summer With Wild & the Moon's Latest Menu Drop! [2538-Views]
Discover the Perfect Gift This Eid Al Adha From Rasasi Perfumes [2517-Views]
Nahdi Medical Company Transforms its Financial Management with Infor [2464-Views]
Dubai Well Poised for Growth in New Business Entities' [2321-Views]
70 Percent of Businesses Increase or Maintain Digital Transformation Spend Amid Pandemic, ... [2296-Views]
Kia Launches ‘Live Stream Showroom' to Offer Customers an Innovative Digital Experience [2255-Views]
Toric Tourbillon Slate'' [2247-Views]
IMG Worlds is Back This Friday Park Entry Price at AED 20 Only [2243-Views]
Amp Up Your Beauty Routine With New Products From Missha Cosmetics [2218-Views]
Alstom at Forefront of Hygiene & Safety Innovation for Transport & Mobility in a COVID-19 ... [2185-Views]
UAE Ranks in Top 10 on Kpmg's 2020 Global Autonomous Vehicles Readiness Index, for Third C... [2181-Views]
Comprehensive Study of Refugee Children's Academic, Social, and Emotional Learning Outcome... [2173-Views]
Celebrate Eid with Steve Madden [2050-Views]
Three UAE Students Bag Coveted Princess Diana Award for Outstanding Social Initiative [2046-Views]
17-Year Old Smashed a Guinness World Records Title in His Bedroom [2029-Views]
Dubai Sports World Marks Official Opening at Dubai World Trade Centre [2013-Views]
Dubai Startup Hub and Dtec Announce Winners of Emirati Development Programme [1993-Views]
Dubai Culture Wins Excellence Award From Arab Federation for Libraries and Information [1968-Views]
Champion Cleaners Launch New Home and Office Sanitization Service [1919-Views]
Al Habtoor Motors Launches Summer Surprises Stock clearance on Mitsubishi SUVs 2019 Model... [1911-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories